{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:02:49Z","timestamp":1787497369322,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jad.2019.03.078","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T13:08:33Z","timestamp":1553605713000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Mental health and cognitive function responses to quetiapine in patients with methamphetamine abuse under methadone maintenance treatment"],"prefix":"10.1016","volume":"251","author":[{"given":"Najme Sadat","family":"Javdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Sadat","family":"Ghoreishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Sehat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Banafshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9 Suppl","key":"10.1016\/j.jad.2019.03.078_bib0001","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","article-title":"Compendium of physical activities: an update of activity codes and MET intensities","volume":"32","author":"Ainsworth","year":"2000","journal-title":"Med. Sci. Sports Exerc."},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2008-2231-21-30","article-title":"Methamphetamine-associated psychosis: a new health challenge in Iran","volume":"21","author":"Alam Mehrjerdi","year":"2013","journal-title":"Daru"},{"key":"10.1016\/j.jad.2019.03.078_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajp.2018.01.001","article-title":"Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern","volume":"31","author":"Alammehrjerdi","year":"2018","journal-title":"Asian J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2019.03.078_bib0004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11597330-000000000-00000","article-title":"Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study","volume":"32","author":"Altamura","year":"2012","journal-title":"Clin. drug Investig."},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2147\/NDT.S3238","article-title":"New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine","volume":"4","author":"Baune","year":"2008","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0006","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2019.03.078_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2019.03.078_bib0008","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1046\/j.1460-9568.2002.02311.x","article-title":"Increased BDNF and trk-B mRNA expression in cortical and limbic regions following formation of a social recognition memory","volume":"16","author":"Broad","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0009","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1034\/j.1399-5618.2002.02229.x","article-title":"Quetiapine in bipolar disorder and cocaine dependence","volume":"4","author":"Brown","year":"2002","journal-title":"Bipolar Disord."},{"issue":"11","key":"10.1016\/j.jad.2019.03.078_bib0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0006-3223(94)90082-5","article-title":"The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance","volume":"36","author":"Buchanan","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0011","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1037\/a0013510","article-title":"The relative impact of nicotine dependence, other substance dependence, and gender on Bechara Gambling Task performance","volume":"16","author":"Businelle","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0013","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1097-4679(197701)33:1+<194::AID-JCLP2270330143>3.0.CO;2-T","article-title":"A comparison of empirically derived groups of aphasic patients on the Neurosensory Center Comprehensive Examination for Aphasia","volume":"33","author":"Crockett","year":"1977","journal-title":"J. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0376-8716(03)00187-X","article-title":"A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system","volume":"72","author":"Dolan","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"13","key":"10.1016\/j.jad.2019.03.078_bib0015","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00001756-200409150-00022","article-title":"Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801","volume":"15","author":"Fumagalli","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.jad.2019.03.078_bib0016","article-title":"The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment","author":"Ghaderi","year":"2018","journal-title":"Addict. Biol."},{"issue":"Pt B","key":"10.1016\/j.jad.2019.03.078_bib0017","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pnpbp.2017.06.016","article-title":"Clinical trial of the effects of vitamin D supplementation on psychological symptoms and metabolic profiles in maintenance methadone treatment patients","volume":"79","author":"Ghaderi","year":"2017","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2019.03.078_bib0018","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.19082\/5354","article-title":"Gender differences in substance use patterns and disorders among an Iranian patient sample receiving methadone maintenance treatment","volume":"9","author":"Ghaderi","year":"2017","journal-title":"Electron. Phys."},{"issue":"4","key":"10.1016\/j.jad.2019.03.078_bib0019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/NMD.0b013e31819db6fe","article-title":"Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up","volume":"197","author":"Glasner-Edwards","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"issue":"5","key":"10.1016\/j.jad.2019.03.078_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1521-0391.2010.00061.x","article-title":"Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning","volume":"19","author":"Glasner-Edwards","year":"2010","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2006.04.009","article-title":"The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats","volume":"172","author":"He","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0022","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.jad.2019.03.078_bib0023","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/13803395.2010.516743","article-title":"Use of the Wechsler Adult Intelligence Scale Digit Span subtest for malingering detection: a meta-analytic review","volume":"33","author":"Jasinski","year":"2011","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0024","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/YIC.0b013e32833e34d9","article-title":"Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial","volume":"26","author":"Katzman","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2019.03.078_bib0026","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1038\/tp.2013.19","article-title":"Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle\/fate control","volume":"3","author":"Kondo","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2019.03.078_bib0027","article-title":"Derived trail making test indices: a preliminary report","author":"Lamberty","year":"1994","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.psychres.2014.05.026","article-title":"The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders","volume":"219","author":"Mahoney","year":"2014","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.jad.2019.03.078_bib0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hup.944","article-title":"Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics","volume":"23","author":"Martinotti","year":"2008","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0030","first-page":"10","article-title":"The prevalence of methamphetamine dependence among Iranian women in methadone maintenance therapy in Tehran, Iran","volume":"13","author":"Massah","year":"2018","journal-title":"Iran. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0031","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-3223(03)00785-6","article-title":"Brain-derived neurotrophic factor rescues neuronal death induced by methamphetamine","volume":"55","author":"Matsuzaki","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0032","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0956462413512806","article-title":"Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran","volume":"25","author":"Mehrjerdi","year":"2014","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.jad.2019.03.078_bib0033","article-title":"Psychosocial interventions for psychostimulant misuse","author":"Minozzi","year":"2016","journal-title":"Cochrane Library"},{"issue":"5","key":"10.1016\/j.jad.2019.03.078_bib0034","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.jcp.0000138763.23482.2a","article-title":"Quetiapine for treatment of alcohol dependence","volume":"24","author":"Monnelly","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2019.03.078_bib0035","article-title":"Amphetamine-type stimulants in a group of adults in Tehran, Iran: a rapid situation assessment in twenty-two districts","volume":"10","author":"Noori","year":"2016","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"key":"10.1016\/j.jad.2019.03.078_bib0036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neuropharm.2014.04.002","article-title":"Psychostimulant addiction treatment","volume":"87","author":"Phillips","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.jad.2019.03.078_bib0037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1207\/s15324826an0604_7","article-title":"Validity of the Ward seven-subtest WAIS-III short form in a neuropsychological population","volume":"6","author":"Pilgrim","year":"1999","journal-title":"Appl. Neuropsychol."},{"key":"10.1016\/j.jad.2019.03.078_bib0038","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","article-title":"Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis","volume":"80","author":"Potvin","year":"2018","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0039","first-page":"137","article-title":"Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol","volume":"26","author":"Purdon","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/schbul\/sbp062","article-title":"Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis","volume":"37","author":"Robles","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.jad.2019.03.078_bib0041","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.intell.2011.03.001","article-title":"What cognitive abilities are involved in trail-making performance?","volume":"39","author":"Salthouse","year":"2011","journal-title":"Intelligence"},{"issue":"Suppl","key":"10.1016\/j.jad.2019.03.078_bib0042","first-page":"75","article-title":"Human placental extract ameliorates structural lung changes induced by Amiodarone in Rats","volume":"15","author":"Samiei","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"issue":"6","key":"10.1016\/j.jad.2019.03.078_bib0043","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1139\/jpn.0444","article-title":"Potential benefits of quetiapine in the treatment of substance dependence disorders","volume":"29","author":"Sattar","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0044","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1037\/1040-3590.13.2.230","article-title":"The trail making test: a study in focal lesion patients","volume":"13","author":"Stuss","year":"2001","journal-title":"Psychol. Assess."},{"issue":"4","key":"10.1016\/j.jad.2019.03.078_bib0045","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.3778","article-title":"Six-month outcomes of a web-based intervention for users of amphetamine-type stimulants: randomized controlled trial","volume":"17","author":"Tait","year":"2015","journal-title":"J. Med. Internet Res."},{"issue":"1","key":"10.1016\/j.jad.2019.03.078_bib0046","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","article-title":"Psychotropic drugs and liver disease: a critical review of pharmacokinetics and liver toxicity","volume":"8","author":"Telles-Correia","year":"2017","journal-title":"World J. Gastrointestinal Pharmacol. Therap."},{"key":"10.1016\/j.jad.2019.03.078_bib0047","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fpsyg.2014.00162","article-title":"Emotion-based learning: insights from the Iowa Gambling Task","volume":"5","author":"Turnbull","year":"2014","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.jad.2019.03.078_bib0048","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11126-011-9201-3","article-title":"Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trial","volume":"83","author":"Urben","year":"2012","journal-title":"Psychiatr. Q."},{"issue":"2","key":"10.1016\/j.jad.2019.03.078_bib0049","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ajad.12505","article-title":"Pattern and related factors of cognitive impairment among chronic methamphetamine users","volume":"26","author":"Wang","year":"2017","journal-title":"Am. J. Addict."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719302903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719302903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:25:18Z","timestamp":1759022718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719302903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":49,"alternative-id":["S0165032719302903"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.03.078","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mental health and cognitive function responses to quetiapine in patients with methamphetamine abuse under methadone maintenance treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.03.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}